Update shared on10 Sep 2025
Fair value Increased 0.52%Analysts view AMETEK’s valuation as fair amid positive sentiment on the Faro Technologies acquisition and potential margin relief from tariffs, though cautious outlooks persist due to clean tech and healthcare uncertainties and the lack of compelling near-term catalysts, resulting in a marginal price target increase from $204.88 to $205.94.
Analyst Commentary
- Valuation seen as fair by several analysts, with the current price reflecting expectations for growth and margins.
- Recent acquisition of Faro Technologies viewed positively for cost synergies and future opportunity as negative catalysts subside.
- Margin relief possible due to tariffs, but ongoing uncertainty regarding tariff resolutions tempers the near-term outlook.
- Lingering concerns over the impact of the Big Beautiful Bill on clean tech and healthcare end markets are contributing to analyst caution.
- No compelling catalyst for material outperformance identified in the near term, leading to several Hold or neutral stances.
What's in the News
- Repurchased 632 shares for $0.11 million, completing buyback of 40,350 shares for $7.07 million under the February 2025 program.
- Expects Q3 sales to grow mid-single digits year-over-year, with diluted EPS guidance of $1.50 to $1.54.
- Raised full-year 2025 guidance to mid-single digit sales growth, with diluted EPS expected between $6.15 and $6.29.
- Reaffirmed focus on strategic acquisitions, highlighting a robust pipeline and strong balance sheet to support future deals.
Valuation Changes
Summary of Valuation Changes for AMETEK
- The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from $204.88 to $205.94.
- The Future P/E for AMETEK remained effectively unchanged, moving only marginally from 32.32x to 32.48x.
- The Discount Rate for AMETEK remained effectively unchanged, moving only marginally from 8.74% to 8.73%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.